title: Acute ventilator-induced vascular permeability and cytokine responses in isolated and in situ mouse lungs.
abstract: To determine the influence of experimental model and strain differences on the relationship of vascular permeability to inflammatory cytokine production after high peak inflation pressure (PIP) ventilation, we used isolated perfused mouse lung and intact mouse preparations of Balb/c and B6/129 mice ventilated at high and low PIP. Filtration coefficients in isolated lungs and bronchoalveolar lavage (BAL) albumin in intact mice increased within 20-30 min after initiation of high PIP in isolated Balb/c lungs and intact Balb/c, B6/129 wild-type, and p55 and p75 tumor necrosis factor (TNF) dual-receptor null mice. In contrast, the cytokine response was delayed and variable compared with the permeability response. In isolated Balb/c lungs ventilated with 25-27 cmH(2)O PIP, TNF-alpha, interleukin (IL)-1 beta, IL-1 alpha, macrophage inflammatory protein (MIP)-2, and IL-6 concentrations in perfusate were markedly increased in perfusate at 2 and 4 h, but only MIP-2 was detectable in intact Balb/c mice using the same PIP. In intact wild-type and TNF dual-receptor null mice with ventilation at 45 cmH(2)O PIP, the MIP-2 and IL-6 levels in BAL were significantly increased after 2 h in both groups, but there were no differences between groups in the BAL albumin and cytokine concentrations or in lung wet-to-dry weight ratios. TNF-alpha was not be detected in BAL fluids in any group of intact mice. These results suggest that the alveolar hyperpermeability induced by high PIP ventilation occurs very rapidly and is initially independent of TNF-alpha participation and unlikely to depend on MIP-2 or IL-6.
authors.affiliation: Dept. of Physiology, College of Medicine, University of South Alabama, Mobile, AL 36688, USA.
authors.forename: S
authors.initials: S
authors.lastname: Yoshikawa
authors.forename: J A
authors.initials: JA
authors.lastname: King
authors.forename: R N
authors.initials: RN
authors.lastname: Lausch
authors.forename: A M
authors.initials: AM
authors.lastname: Penton
authors.forename: F G
authors.initials: FG
authors.lastname: Eyal
authors.forename: J C
authors.initials: JC
authors.lastname: Parker
mesh_terms: D000208:Acute Disease; D000418:Albumins / Q000378:metabolism; D000818:Animals; D002245:Carbon Dioxide / Q000097:blood; D054426:Chemokine CXCL2; D018925:Chemokines / Q000378:metabolism; D016207:Cytokines / Q000378:metabolism*; D007375:Interleukin-1 / Q000378:metabolism; D015850:Interleukin-6 / Q000378:metabolism; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D018345:Mice, Knockout; D008833:Microcirculation / Q000502:physiology; D008854:Microscopy, Electron; D010100:Oxygen / Q000097:blood; D011650:Pulmonary Alveoli / Q000378:metabolism / Q000503:physiopathology* / Q000648:ultrastructure; D011652:Pulmonary Circulation / Q000502:physiology; D011654:Pulmonary Edema / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology; D018124:Receptors, Tumor Necrosis Factor / Q000235:genetics; D012121:Respiration, Artificial / Q000009:adverse effects*; D012128:Respiratory Distress Syndrome / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
chemical_list: D000418:Albumins; D054426:Chemokine CXCL2; D018925:Chemokines; C404915:Cxcl2 protein, mouse; D016207:Cytokines; D007375:Interleukin-1; D015850:Interleukin-6; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D002245:Carbon Dioxide; D010100:Oxygen